Journal article

The dearth of new antibiotic development: why we should be worried and what we can do about it

PGP Charles, ML Grayson

The Medical Journal of Australia | AUSTRALASIAN MED PUBL CO LTD | Published : 2004

Abstract

The emergence and spread of multidrug-resistant pathogens has increased substantially over the past 20 years. Over the same period, the development of new antibiotics has decreased alarmingly, with many pharmaceutical companies pulling out of antibiotic research in favour of developing "lifestyle" drugs. Reasons given for withdrawing from antibiotic development include poor "net present value" status of antibiotics, changes in regulations requiring larger drug trials and prolonged post-marketing surveillance, clinical preference for narrow-spectrum rather than broad-spectrum agents, and high new-drug purchase costs. Major improvements in infection control in Australia are needed to prevent f..

View full abstract

University of Melbourne Researchers